Cargando…

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation

OBJECTIVE: Cerebral microbleeds (CMBs) are a magnetic resonance imaging (MRI) marker for cerebral small vessel disease. Existing CMBs and those that newly develop are associated with the risks of stroke incidence and recurrence. The purpose of the present study was to investigate the association of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umemura, Toshitaka, Mashita, Shinichi, Kawamura, Takahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498025/ https://www.ncbi.nlm.nih.gov/pubmed/32941455 http://dx.doi.org/10.1371/journal.pone.0238456

Ejemplares similares

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke
por: Umemura, Toshitaka, et al.
Publicado: (2016)

Cardioembolic stroke with hemorrhagic transformation in atrial fibrillation patients on anticoagulant therapy: A case report
por: Wulandari, Wulandari, et al.
Publicado: (2023)

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022)

Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy
por: Hirata, Yoshinori, et al.
Publicado: (2022)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Association of Chronic Kidney Disease and Cerebral Small Vessel Disease with Cognitive Impairment in Elderly Patients with Type 2 Diabetes
por: Umemura, Toshitaka, et al.
Publicado: (2013)

Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes
por: Benavente, Lorena, et al.
Publicado: (2010)

Sepsis as an independent risk factor in atrial fibrillation and cardioembolic stroke
por: Leng, Yiming, et al.
Publicado: (2023)

Incidence of cardioembolic stroke related to atrial fibrillation in Joinville, Brazil
por: Diegolli, Henrique, et al.
Publicado: (2023)

Effect of Alteplase Use on Outcomes in Patients With Atrial Fibrillation: Analysis of the Initiation of Anticoagulation After Cardioembolic Stroke Study
por: Yaghi, Shadi, et al.
Publicado: (2021)

Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage
por: Leithäuser, Boris, et al.
Publicado: (2009)

Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke
por: Yang, Pil-Sung, et al.
Publicado: (2018)

Determinants of Visceral Infarction in Acute Cardioembolic Stroke Due to Atrial Fibrillation
por: Sohn, Sung-Il, et al.
Publicado: (2021)

Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation
por: Nguyen, Van, et al.
Publicado: (2022)

Acute Cardioembolic Stroke in the Setting of Subtherapeutic Anticoagulation
por: Ambatipudi, Ankit, et al.
Publicado: (2023)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Atrial cardiopathy is associated with cerebral microbleeds in ischemic stroke patients
por: Zhao, David X., et al.
Publicado: (2022)

Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
por: Pulit, Sara L., et al.
Publicado: (2018)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
por: Yasuda, Ken, et al.
Publicado: (2018)

Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?
por: Jurjans, Kristaps, et al.
Publicado: (2019)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
por: Cheng, Yajun, et al.
Publicado: (2019)

Association between Coagulation Function and Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
por: Liu, Junfeng, et al.
Publicado: (2017)

Association Between Slow Ventricular Response and Severe Stroke in Atrial Fibrillation-Related Cardioembolic Stroke
por: Ha, Sang Hee, et al.
Publicado: (2023)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Cerebral microbleeds: a new dilemma in stroke medicine
por: Kakar, Puneet, et al.
Publicado: (2012)

Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017)

Is Left Atrial Appendage Occlusion Really Efficacious in Avoiding Administrating Anticoagulant Drugs for the Prevention of Cardioembolic Events in Patients With Atrial Fibrillation?
por: De Vecchis, Renato, et al.
Publicado: (2019)

Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients
por: Jurjāns, Kristaps, et al.
Publicado: (2022)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
por: Wang, Jiayu, et al.
Publicado: (2019)

2386 Associations of transthoracic echocardiographic features with cardioembolic stroke among patients without atrial fibrillation
por: Johansen, Michelle C., et al.
Publicado: (2018)

The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation
por: Jung, Yo-Han, et al.
Publicado: (2023)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants
por: Wańkowicz, Paweł, et al.
Publicado: (2021)

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
por: Wilson, Duncan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1d7bvgc1lfo9s5ef355mb5nrh2